Managing adults with congenital heart disease in the catheterization laboratory: state of the art

2010 ◽  
Vol 8 (12) ◽  
pp. 1741-1752 ◽  
Author(s):  
Simon T MacDonald ◽  
Mario Carminati ◽  
Massimo Chessa
2012 ◽  
Vol 8 (2) ◽  
pp. 111-116 ◽  
Author(s):  
Nicole J. Sutton ◽  
Mark A. Greenberg ◽  
Mark A. Menegus ◽  
George Lui ◽  
Robert H. Pass

1986 ◽  
Vol 12 (4) ◽  
pp. 215-218 ◽  
Author(s):  
Michael F. Flanagan ◽  
George F. Leatherman ◽  
Alexa Carls ◽  
John F. Keane ◽  
Andrew P. Selwyn ◽  
...  

2019 ◽  
Vol 124 (12) ◽  
pp. 1238-1252 ◽  
Author(s):  
Nicolò Schicchi ◽  
Marco Fogante ◽  
Paolo Esposto Pirani ◽  
Giacomo Agliata ◽  
Maria Chiara Basile ◽  
...  

2018 ◽  
Author(s):  
Douglas Atkinson ◽  
Viviane G Nasr

Congenital heart disease is the most common congenital malformation with an incidence of 4 to 10 per 1,000 live births. Anesthesiologists are required to manage these patients when they present for surgical or percutaneous interventions, including definitive and/or palliative procedures. The preoperative evaluation of the cardiac patient includes a thorough physical examination, laboratory testing, and diagnostic imaging such as echocardiography and magnetic resonance imaging. The perioperative management of children with cardiac disease requires a thorough understanding of the underlying pathophysiology, invasive monitoring such as arterial pressure and central venous pressure, and different surgical procedures and interventions in the catheterization laboratory. In addition, understanding cardiopulmonary bypass including perfusion, temperature, and acid-base is a must. This chapter presents a systematic approach for the preoperative assessment of children with cardiac disease and management on cardiopulmonary bypass and discusses the different surgical procedures and catheterization laboratory interventions, indications, and potential complications. This review contains 1 figure, 9 tables, and 23 references. Key Words: associated anomalies, cardiac surgical procedures, cardiopulmonary bypass, congenital heart disease, intraoperative monitoring, inotropes, interventional catheterization, preoperative evaluation, vasodilators


PEDIATRICS ◽  
1973 ◽  
Vol 52 (6) ◽  
pp. 899-899
Author(s):  
Carl N. Steeg

This volume seeks to present the current "state of the art in pediatric cardiology." It is an immensely readable work which has a distinguished roster of contributors who have broadly covered both newer clinical and investigative aspects of heart disease in children, as well as reviewing ever current topics such as the cyanotic newborn, congestive failure, innocent murmurs, electrocardiography, and radiography of patients with congenital heart disease, to mention a few. Other chapters deal with such subjects as neuropharmacologic studies of the perinatal myocardium, embryology and morphology of the normal and abnormal heart, pediatric aspects of atherosclerosis, surgical treatment of tetralogy of Fallot, and the pharmacology of cardio-active agents.


Children ◽  
2019 ◽  
Vol 6 (3) ◽  
pp. 42 ◽  
Author(s):  
P. Syamasundar Rao

Since the description of surgery for patent ductus arteriosus in late 1930s, an innumerable number of advances have taken place in the management of congenital heart defects (CHDs). In this review the current status of treatment of seven of the most common acyanotic CHDs was reviewed. The discussion included indications for, and timing of, intervention and methods of intervention. The indications are, by and large, determined by the severity of the lesion. Pressure gradients in obstructive lesions and the magnitude of the shunt in left-to-right shunt lesions are used to assess the severity of the lesion. The timing of intervention is different for each lesion and largely dependent upon when the criteria for indications for intervention were met. Appropriate medical management is necessary in most patients. Trans-catheter methods are preferable in some defects while surgery is a better option in some other defects. The currently available medical, trans-catheter, and surgical methods to treat acyanotic CHD are feasible, safe, and effective.


2012 ◽  
Vol 34 (1) ◽  
pp. 39-45 ◽  
Author(s):  
John Senga ◽  
Emmanuel Rusingiza ◽  
Joseph Mucumbitsi ◽  
Agnès Binagwaho ◽  
Bert Suys ◽  
...  

Diagnostics ◽  
2020 ◽  
Vol 11 (1) ◽  
pp. 49
Author(s):  
Katharina Meinel ◽  
Martin Koestenberger ◽  
Hannes Sallmon ◽  
Georg Hansmann ◽  
Guido E. Pieles

While invasive assessment of hemodynamics and testing of acute vasoreactivity in the catheterization laboratory is the gold standard for diagnosing pulmonary hypertension (PH) and pulmonary vascular disease (PVD) in children, transthoracic echocardiography (TTE) serves as the initial diagnostic tool. International guidelines suggest several key echocardiographic variables and indices for the screening studies when PH is suspected. However, due to the complex anatomy and special physiological considerations, these may not apply to patients with congenital heart disease (CHD). Misinterpretation of TTE variables can lead to delayed diagnosis and therapy, with fatal consequences, or–on the other hand-unnecessary invasive diagnostic procedures that have relevant risks, especially in the pediatric age group. We herein provide an overview of the echocardiographic workup of children and adolescents with PH with a special focus on children with CHD, such as ventricular/atrial septal defects, tetralogy of Fallot or univentricular physiology. In addition, we address the use of echocardiography as a tool to assess eligibility for exercise and sports, a major determinant of quality of life and outcome in patients with PH associated with CHD.


Sign in / Sign up

Export Citation Format

Share Document